Endothelial Function and COVID-19

Completed

Conditions studied: COVID-19

In brief

The present study aims to investigate the endothelial vasodilator function in patients with COVID-19

Key facts

Study ID

NCT04525443

Run by

Hospital San Carlos, Madrid

People needed

110

Starts

2020-06-03

Expected to finish

2021-02-11

Last updated by the study team

2021-02-26

Who can join

Age: any. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Study group No. 1: age ≥ 18 years; COVID-19 confirmed with positive PCR. Availability of informed consent.
• Study group No. 2: age ≥ 18 years; Past SARS-CoV-2 infection demonstrated by PCR and serology.
• Control group: age ≥ 18 years; absence of concurrent or previous SARS-CoV2 infection demonstrated by serology, and absence of acute or chronic diseases related to endothelial dysfunction, mainly acute or chronic infectious or inflammatory processes and known peripheral vascular disease.

You may not qualify if…

• Impossibility of performing the endothelial function test.
• Recent puncture of the radial artery (<15 days).
• Hemodynamic instability.
• Unavailability of signed informed consent.

Where it is running

• Mayo Clinic — Rochester, Minnesota, United States
• Hospital Clínico San Carlos — Madrid, Spain

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.